InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Brazil’s new process for examining pharma patents faces scepticism

Michael Loney, New York


A new procedure for approving pharmaceutical patents in Brazil comes into effect on June 12 with the aim of ending the arduous double examination by the BPTO and Anvisa. Uncertainties such as whether the national health agency will be happy to be overruled by BPTO will need to be resolved to overcome doubts, however

On June 12 a new procedure for prosecuting pharmaceutical patents in Brazil comes into effect that practitioners hope will greatly improve what has been a huge source of frustration.

But they’ll believe it when they see it.

"Everyone is...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates

Supplements